ReadSoft signs USD 350,000 deal with global biopharmaceut...

ReadSoft signs USD 350,000 deal with global biopharmaceutical company

A U.S. based global biopharmaceutical company has decided to invest more than USD 350,000 in ReadSoft's invoice automation solutions for SAP. The agreement was signed in September 2008 and covers the processing of tens of thousands of invoices annually. The solution from ReadSoft will be implemented at the company's offices in the U.S. as well as in several European countries.

This international biopharmaceutical company, a member of the Fortune 1000, currently employs over 3,000 people in the United States and Europe. The company was looking for an accounts payable solution that could increase both efficiency and visibility. With a strong existing customer base in the pharmaceutical industry and tight integration with SAP, ReadSoft soon became the number one choice.

The agreement will involve rolling out ReadSoft's solutions across their A/P department allowing the customer to make better use of its staff, ensure higher-quality information, and reduce costs.

"We are delighted to secure the agreement with this pharmaceutical company as it gives further evidence to our invoice automation solution residing inside SAP across all industry sectors," says Jan Andersson, President and CEO of ReadSoft.